Domenico Di Marzo

p53 Suppresses the Nrf2-dependent Transcription of Antioxidant Response Genes*

T. Russo, F. Cimino, M. Napolitano, 2006, Journal of Biological Chemistry.

Abrogating G2/M checkpoint through WEE1 inhibition in combination with chemotherapy as a promising therapeutic approach for mesothelioma

A. Giordano, F. Pentimalli, I. Forte, 2014, Cancer biology & therapy.

Antineoplastic activity of povidone-iodine on different mesothelioma cell lines: results of in vitro study.

A. Fiorelli, M. Santini, A. Giordano, 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

pRb2/p130 Localizes to the Cytoplasm in Diffuse Gastric Cancer

A. Giordano, F. Roviello, Letizia Cito, 2015, Journal of cellular physiology.

Let‐7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma‐Derived 3AB‐OS Cancer Stem Cells

A. Giordano, F. Pentimalli, I. Forte, 2016, Journal of cellular physiology.

MicroRNA-29b-1 impairs in vitro cell proliferation, self-renewal and chemoresistance of human osteosarcoma 3AB-OS cancer stem cells

A. Giordano, F. Pentimalli, I. Forte, 2014, International journal of oncology.

P53-regulated miR-320a targets PDL1 and is downregulated in malignant mesothelioma

A. Giordano, L. Mutti, F. Pentimalli, 2020, Cell Death & Disease.

SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation

A. Giordano, S. Schenone, A. Angelucci, 2015, Oncotarget.

Targeted therapy based on p53 reactivation reduces both glioblastoma cell growth and resistance to temozolomide.

A. Giordano, F. Pentimalli, I. Forte, 2019, International journal of oncology.

Pharmacological targeting of p53 through RITA is an effective antitumoral strategy for malignant pleural mesothelioma

A. Giordano, F. Pentimalli, I. Forte, 2014, Cell cycle.